Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms like disorganized thinking or executive dysfunction. As a result, many ...
Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.
An estimated 16.9 million cancer survivors have reported cognitive deficits, which can interfere with everyday activities. Cognitive impairment may include difficulty with memory, attention, language, ...
Researchers discover that a mutation in the grin2a gene impairs a thalamocortical brain circuit, preventing the brain from ...
Post-COVID-19 condition (PCC) involves persistent symptoms like fatigue and cognitive dysfunction, affecting 8.4% of US adults. A randomized clinical trial showed cognitive and behavioral ...
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. People who have had prior SARS-CoV-2 infection report significantly more symptoms of cognitive ...
Morning Overview on MSN
Study links glymphatic system dysfunction to hallucinations
Researchers studying a rare genetic condition tied to high psychosis risk have found that the brain’s waste-clearing plumbing ...
Thirty-six percent of patients with long COVID-19 conditions reported experiencing cognitive deficits after 30 days, according to new research published May 5 in JAMA. Researchers from the University ...
In multiple sclerosis (MS), the body attacks myelin, the protective coating of nerves in the brain. This leads to various symptoms, such as memory issues, fatigue, lack of concentration, slow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results